These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
758 related articles for article (PubMed ID: 36111766)
1. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art. Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766 [TBL] [Abstract][Full Text] [Related]
2. Gut microbiota, inflammatory bowel disease and colorectal cancer. Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in the pathogenesis of inflammatory bowel disease. Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689 [TBL] [Abstract][Full Text] [Related]
4. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081 [TBL] [Abstract][Full Text] [Related]
5. Gut mycobiome: The probable determinative role of fungi in IBD patients. Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192 [TBL] [Abstract][Full Text] [Related]
6. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission. Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243 [TBL] [Abstract][Full Text] [Related]
7. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876 [TBL] [Abstract][Full Text] [Related]
8. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease. Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328 [TBL] [Abstract][Full Text] [Related]
9. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114 [TBL] [Abstract][Full Text] [Related]
10. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781 [TBL] [Abstract][Full Text] [Related]
11. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review. Aldars-GarcĂa L; Marin AC; Chaparro M; Gisbert JP Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883 [TBL] [Abstract][Full Text] [Related]
12. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Stecher B Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088 [TBL] [Abstract][Full Text] [Related]
13. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease. Lv Y; Zhen C; Liu A; Hu Y; Yang G; Xu C; Lou Y; Cheng Q; Luo Y; Yu J; Fang Y; Zhao H; Peng K; Yu Y; Lou J; Chen J; Ni Y mSystems; 2024 Sep; 9(9):e0078324. PubMed ID: 39150251 [TBL] [Abstract][Full Text] [Related]
14. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154 [TBL] [Abstract][Full Text] [Related]
15. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future. Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339 [TBL] [Abstract][Full Text] [Related]
16. Follicular Skin Disorders, Inflammatory Bowel Disease, and the Microbiome: A Systematic Review. Fleshner L; Roster K; Farabi B; Hirani R; Tepper K; Pitchumoni CS; Safai B; Marmon S Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337688 [TBL] [Abstract][Full Text] [Related]
17. Association between intestinal microbiota and inflammatory bowel disease. Zhang Y; Si X; Yang L; Wang H; Sun Y; Liu N Animal Model Exp Med; 2022 Dec; 5(4):311-322. PubMed ID: 35808814 [TBL] [Abstract][Full Text] [Related]
18. Potential effects of nutrition-induced alteration of gut microbiota on inflammatory bowel disease: A review. Tian QB; Chen SJ; Xiao LJ; Xie JQ; Zhao HB; Zhang X J Dig Dis; 2024 Feb; 25(2):78-90. PubMed ID: 38450936 [TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition. Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B; Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA and Gut Microbiota: Tiny but Mighty-Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics. Casado-Bedmar M; Viennois E J Crohns Colitis; 2022 Jul; 16(6):992-1005. PubMed ID: 34918052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]